Korean medical AI company SEERS secures $14.7M UAE contract for heart-monitoring wearables

Patients across the United Arab Emirates could soon wear heart-monitoring devices from Korean medical AI company SEERS to check for irregular heartbeats. The company has signed its first major Middle East contract worth $14.7 million.

SEERS announced Wednesday that it will supply at least 105,000 mobiCARE devices over three years to One Health, the medical device distribution arm of PureHealth, the UAE's largest healthcare group. The deal follows a memorandum of understanding signed between the companies in February at WHX Dubai 2026.

How will it work?

The mobiCARE system works through continuous monitoring and AI analysis:

• Patients wear the device for more than a day while it records the heart's electrical activity
• The electrocardiogram (ECG) data is analyzed by AI to detect signs of arrhythmia
• Doctors receive reports to help decide if patients need additional testing or treatment

Arrhythmia is a condition where the heart beats too fast, too slowly, or irregularly. Early detection can help prevent more serious cardiovascular problems.

Why does it matter?

This contract represents a significant expansion for SEERS beyond its home market. In South Korea, the company already has more than 1,000 medical institutions using mobiCARE, with over 620,000 tests completed by the end of 2024.

The UAE deal gives SEERS access to PureHealth's extensive network, which includes hospitals, clinics, diagnostics, insurance, pharmacies, and healthcare technology across the region. SEERS said it received product approvals in Abu Dhabi and Dubai before signing the contract.

The company plans to use mobiCARE as an entry point before expanding to other products like thynC, a hospital ward monitoring system using wireless wearable devices to track patients' vital signs in real time.

The context

Rising cardiovascular disease rates in the Middle East and North Africa are driving demand for monitoring technologies. SEERS noted that the region also offers higher payment levels for diagnostic and monitoring services compared to Korea, making it an attractive market.

The expansion fits a broader trend of Asian medical technology companies entering Middle Eastern markets as healthcare systems modernize and adopt more digital monitoring solutions. SEERS has already completed proof-of-concept work for its thynC hospital monitoring system at Sheikh Shakhbout Medical City in Abu Dhabi, described by PureHealth as the UAE's largest healthcare complex.

This positions the Korean company to potentially expand across the region as demand for continuous patient monitoring grows beyond traditional hospital settings.